Medicamen Biotech Limited Financial Overview
Medicamen Biotech Limited's market cap is currently ₹5.36B. The company's EPS TTM is ₹1.966; its P/E ratio is 48.18; and it has a dividend yield of 0.26%. Medicamen Biotech Limited is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
